Tahir Mian, MD

In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda.

Identification of risk factors in hypertensive patients: contribution of randomized controlled trials through an individual patient database.

Non-invasive Intratracheal Instillation in Mice.

The history of the wolff-Parkinson-white syndrome.

The case for earlier treatment of HIV infection.

Reassessing the Inclusion of Race in Diagnosing Kidney Diseases: An Interim Report From the NKF-ASN Task Force.

Neuronal migration disorders: Focus on the cytoskeleton and epilepsy.

Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population.

ZSFG Medicine Grand Rounds - MGR 23028

Vinayak Prasad, MD, MPH

Associate Professor, Department of Epidemiology and Biostatistics, UCSF

Learning Objective: 

1. What study designs are best for causal questions in medicine?

2. What are the limits and strengths of randomized trials?

3. How can we improve the design and conduct of ongoing studies?

Disclosure: Planners Jessie Holtzman, MD; Elizabeth Harleman, MD; Melody Davenport-McLaughlin, BA, and Evelina Azarian, BA have stated they have no financial relationships to disclose. Speaker Vinayak Prasad, MD, MPH has disclosed the following:

“All conflicts of interest have been resolved in accordance with the ACCME’s Standards for Commercial Support”

Accreditation: The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  

Webinar Information:

https://ucsf.zoom.us/j/99763437237?pwd=MU82bDVvTitNWVBQRStpY3h1NUFjQT09.

• Meeting ID: 997 6343 7237
• Passcode: 879258

This presentation will be recorded and is accessible through My Access

https://lecture.ucsf.edu/ets/Catalog/Full/ab21c2921423425398199ec7e0720d6a2

How should top-five lists be developed?: what is the next step?

The Hippo effector YAP regulates the response of cancer cells to MAPK pathway inhibitors.

Early and long-term prognosis after vasodilator therapy in the acute phase of myocardial infarction.

Variable piperaquine exposure significantly impacts protective efficacy of monthly dihydroartemisinin-piperaquine for the prevention of malaria in Ugandan children.

Nationwide variability in the use of induction immunosuppression for adult heart transplantation.